Ticker | Company | Dividends Score | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
---|---|---|---|---|---|---|---|---|---|---|---|
KRYS | KRYSTAL BIOTECH INC | $4.53B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
TGTX | TG THERAPEUTICS INC | $2.54B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
SRPT | SAREPTA THERAPEUTICS INC | $12.35B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
CORT | CORCEPT THERAPEUTICS INC | $2.61B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
GMAB | GENMAB A | $18.33B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.80B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
INCY | INCYTE CORP | $11.92B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
BMRN | BIOMARIN PHARMACEUTICAL INC | $15.91B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
HALO | HALOZYME THERAPEUTICS INC | $5.05B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
RPRX | ROYALTY PHARMA PLC | $17.18B | 1.39% | 23.60% | $0.2000 | $0.40 | 27% | 0 | |||
VNDA | VANDA PHARMACEUTICALS INC | $269.28M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
AMLX | AMYLYX PHARMACEUTICALS INC | $135.56M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
EXEL | EXELIXIS INC | $6.44B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
JAZZ | JAZZ PHARMACEUTICALS PLC | $6.89B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
TECH | BIO-TECHNE CORP | $11.88B | 0.42% | 22.70% | $0.0800 | $0.32 | 6% | 1 | 2024-05-10 | 2024-05-24 | |
PBYI | PUMA BIOTECHNOLOGY INC | $239.26M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
BNTX | BIONTECH SE | $21.93B | N/A | 0.00% | $2.1110 | N/A | N/A | 0 | |||
MDXG | MIMEDX GROUP INC | $1.11B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
CPRX | CATALYST PHARMACEUTICALS INC | $1.77B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
NVO | NOVO NORDISK A S | $559.33B | 1.11% | 47.80% | $0.9299 | $1.37 | 20% | 9 | |||
REGN | REGENERON PHARMACEUTICALS INC | $103.31B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
UTHR | UNITED THERAPEUTICS CORP | $11.45B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
VRTX | VERTEX PHARMACEUTICALS INC | $103.36B | N/A | 0.00% | N/A | N/A | N/A | N/A |